Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 94.535 USD -0.18% Market Closed
Market Cap: 239.1B USD

P/E
Price to Earnings

13.9
Current
20.6
Median
20.2
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
13.9
=
Market Cap
237.8B USD
/
Net Income
17.1B USD
Market Cap P/E
US
Merck & Co Inc
NYSE:MRK
237.8B USD 13.9
US
Eli Lilly and Co
NYSE:LLY
771.5B USD 72.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
US
Johnson & Johnson
NYSE:JNJ
391.5B USD 27.8
DK
Novo Nordisk A/S
CSE:NOVO B
2.3T DKK 23.3
CH
Roche Holding AG
SIX:ROG
242.9B CHF 21.1
UK
AstraZeneca PLC
LSE:AZN
186B GBP 34.2
CH
Novartis AG
SIX:NOVN
194.9B CHF 18.5
IE
Endo International PLC
LSE:0Y5F
158.2B USD -54.1
US
Pfizer Inc
NYSE:PFE
145.1B USD 18
FR
Sanofi SA
PAR:SAN
132.4B EUR 23.1
Earnings Growth PEG
US
Merck & Co Inc
NYSE:MRK
Average P/E: 28.1
13.9
17%
0.8
US
Eli Lilly and Co
NYSE:LLY
72.8
48%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
27.8
26%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
23.3
19%
1.2
CH
Roche Holding AG
SIX:ROG
21.1
16%
1.3
UK
AstraZeneca PLC
LSE:AZN
34.2
36%
1
CH
Novartis AG
SIX:NOVN
18.5
16%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -54.1 N/A N/A
US
Pfizer Inc
NYSE:PFE
18
29%
0.6
FR
Sanofi SA
PAR:SAN
23.1
29%
0.8

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
10.4
2-Years Forward
P/E
9.5
3-Years Forward
P/E
8.6